Legend Biotech (LEGN) Finished Goods (2022 - 2023)

Legend Biotech (LEGN) has reported Finished Goods for 2 consecutive years, with $4.0 million the latest figure, recorded in Q3 2023.

• Quarterly Finished Goods changed N/A year-over-year to $4.0 million in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $4.0 million (changed N/A YoY) and the FY2022 annual result came in at $2.7 million, changed N/A from the prior year.
• Finished Goods advanced to $4.0 million in Q3 2023 per LEGN's latest filing, from $3.8 million in the prior quarter.
• Over the last five years, Finished Goods for LEGN reached as high as $4.0 million in Q3 2023 and fell as low as $2.7 million in Q4 2022.